Release Date: 28/10/10 16:37 Summary: Sept 2010 Qtrly Activities Report and Appendix 5B Price Sensitive: Yes Download Document 317.28KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%